Investors > FAQs

FAQs

1. Where is Endo, Inc.’s Common Stock listed?

Our Common Stock currently trade over-the-counter on the OTCQX® Best Market (OTCQX) under the ticker symbol NDOI.

2. When will the Common Stock be listed on the New York Stock Exchange (NYSE)?

Endo continues to work with the appropriate regulators, including the Securities and Exchange Commission, so that the Company’s shares can begin trading on the New York Stock Exchange later in 2024, subject to required approvals and other customary conditions.

3. What is Endo’s ticker symbol?

Endo’s ticker symbol is OTCQX: NDOI.

4. Who is Endo, Inc.’s transfer agent and how does a stockholder contact the agent for account information?

Computershare is our transfer agent and registrar. Stockholders, who wish to change the name and address or ownership of stock, replace lost certificates or obtain other information should contact:

Computershare Trust Company, N.A.
150 Royall Street, Suite 101
Canton, Massachusetts 02021
Telephone: +1 (866) 595-6048 (Toll Free for U.S., U.S. territories and Canada) or +1 (781) 575-2798 (International).
Website: www.computershare.com/investor

Be sure to include your name, address, phone number, e-mail address and a reference to Endo, Inc. on all of your correspondence.

5. How do I trade my shares of Endo, Inc. Common Stock?

Stockholders who wish to trade their Common Stock should contact their broker for additional information and instructions.

6. Does Endo, Inc. pay dividends on its Common Stock?

We do not intend to pay dividends for the foreseeable future.

7. Are the shares being traded those of old Endo or new Endo?

The shares being traded are those of Endo, Inc. They were issued in April 2024 upon the effectiveness of Endo International plc’s Chapter 11 financial restructuring process. As part of the financial restructuring process, the shares of Endo International, plc were cancelled.

8. Are the shares that were issued in the restructuring freely tradable?

Certain of the shares of Common Stock that were issued in the restructuring are freely transferable, while others are subject to securities law or other restrictions. Your broker should have additional information as to whether your shares are freely transferable.

9. When was Endo founded?

Our predecessor company, Endo International plc, was incorporated in Ireland in 2013, but Endo’s history can be traced back to the early 20th century. Endo International plc initiated a financial restructuring process in 2022, with a goal of emerging as a strong growth company.

Endo, Inc. was formed in December 2023 to facilitate the acquisition of substantially all of the assets of Endo International plc. Upon effectiveness of the plan of reorganization, Endo International plc’s operating assets exited the Chapter 11 financial restructuring process with significantly reduced outstanding indebtedness and resolution of Endo International plc’s pre-bankruptcy litigation overhang.

More about our history can be found in the History section of this website.

10. Where can I get copies of documents filed with the OTC Markets Group?

Endo, Inc.’s filings with OTC Markets Group can be accessed at: https://www.otcmarkets.com/stock/NDOI/overview

If you require a printed copy of any of these documents, you can request it by emailing investor.relations@endo.com. 


For all other questions, email investor.relations@endo.com.